Related Articles
FGFR inhibitor BGJ398 and HDAC inhibitor OBP-801 synergistically inhibit cell growth and induce apoptosis in bladder cancer cells
Histone deacetylase inhibitor OBP‑801 and amrubicin synergistically inhibit the growth of squamous cell lung carcinoma by inducing mitochondrial ASK1‑dependent apoptosis
OBP‑801, a novel histone deacetylase inhibitor, induces M‑phase arrest and apoptosis in rhabdomyosarcoma cells
Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells
Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine